Pharmacy

Six years after regulators approved Amjevita, a biosimilar to the nation's most lucrative drug, Humira, Amgen's drug jumped on the U.S. market Jan. 31 with two list prices.

Civica has selected Ypsomed AG as its manufacturer and supplier of insulin dosing injector pens.

A federal appeals court ruled in favor of three drugmakers Jan. 30 in a case over requirements of whether they should give 340B drug pricing discounts to contract pharmacies. 

Humira, AbbVie's anti-inflammatory drug that has dozens of patents and $114 billion in U.S. sales, has a tight grasp on its market. That's soon to change, The New York Times reported Jan. 28. 

Sen. Elizabeth Warren penned a letter Jan. 25 asking the Federal Trade Commission to "closely scrutinize" two proposed pharma deals: Amgen and Horizon Therapeutics, and Indivior and Opiant. 

Two national chains will reduce operation hours at their pharmacies this spring, The Wall Street Journal reported Jan. 27. 

On Jan. 26, the FDA revoked its emergency use authorization for Evusheld, a monoclonal antibody authorized to treat COVID-19, after finding it's ineffective against about 90 percent of circulating variants. 

RescriptionTM aims to dramatically reduce the cost of prescription drugs for the state’s employers and their employees

Sinai Chicago, which represents Mount Sinai Hospital, Holy Cross Hospital, Sinai Children's Hospital and other medical organizations, partnered with CVS Health Jan. 26 to join the latter's Community Equity Alliance. 

The FDA's advisory committee on antimicrobial drugs on Jan. 25 recommended rezafungin be approved to treat candidemia and invasive candidiasis in adults with limited or no alternative treatment option.